Search Results 1 – 20 of 69
Pre-exposure Prophylaxis (PrEP) to Reduce the Risk of Acquiring HIV During Periconception, Antepartum, and Postpartum Periods
HHS Adults and Adolescents Antiretroviral Guidelines Panel Recommendation for the Long-Acting Injectable Antiretroviral Regimen of Cabotegravir and Rilpivirine
Talaromycosis (Formerly Penicilliosis)
Appendix B: Panel Roster and Financial Disclosures
Preconception Counseling and Care for Women of Childbearing Age Living with HIV
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Tables
Cytomegalovirus Disease
Limitations to Treatment Safety and Efficacy
Considerations for Antiretroviral Use in Patients with Coinfections
Appendix A: Key to Acronyms
Antepartum Care
Appendix B: Drug Characteristics Tables
Laboratory Testing
Management of the Treatment-Experienced Patient
Management of Infants Born to Women with HIV Infection
Drug-Drug Interactions
Introduction
Bacterial Enteric Infections
Cryptosporidiosis